Ching‐Hon Pui
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Lymphoblastic Leukemia research 392
- Hematology 220
- Acute Myeloid Leukemia Research 160
- Chronic Myeloid Leukemia Treatments 56
- Hematopoietic Stem Cell Transplantation 34
- Co-authors
- William E. Evans (123 shared papers)Mary V. Relling (163 shared papers)James R. Downing (51 shared papers)Raul C. Ribeiro (129 shared papers)Scott C. Howard (59 shared papers)Dario Campana (64 shared papers)Jeffrey E. Rubnitz (110 shared papers)John T. Sandlund (82 shared papers)
- Journals
- Blood (112 papers)Journal of Clinical Oncology (85 papers)Cancer (42 papers)Pediatric Blood & Cancer (37 papers)New England Journal of Medicine (14 papers)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Ching‐Hon Pui
642 papers receiving 49.2k citations
Ching‐Hon Pui's Hit Papers
Peers
Comparison fields: 5 of 183
- Hematology 16.6k
- Public Health, Environmental and Occupational Health 26.1k
- Pediatrics, Perinatology and Child Health 13.8k
- Genetics 4.5k
- Oncology 7.7k
Countries citing papers authored by Ching‐Hon Pui
This map shows the geographic impact of Ching‐Hon Pui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Hon Pui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Hon Pui more than expected).
Fields of papers citing papers by Ching‐Hon Pui
This network shows the impact of papers produced by Ching‐Hon Pui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Hon Pui. The network helps show where Ching‐Hon Pui may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching‐Hon Pui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 656 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Hit paper breakdown → | 2002 | 1508 |
| 2 | Treatment of Acute Lymphoblastic Leukemia Hit paper breakdown → | 2006 | 1491 |
| 3 | Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Hit paper breakdown → | 2007 | 1320 |
| 4 | Acute lymphoblastic leukaemia Hit paper breakdown → | 2008 | 1143 |
| 5 | Acute Lymphoblastic Leukemia Hit paper breakdown → | 2004 | 906 |
| 6 | Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia Hit paper breakdown → | 2002 | 888 |
| 7 | BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros Hit paper breakdown → | 2008 | 770 |
| 8 | Acute Lymphoblastic Leukemia Hit paper breakdown → | 1998 | 687 |
| 9 | Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia Hit paper breakdown → | 2009 | 672 |
| 10 | The Tumor Lysis Syndrome Hit paper breakdown → | 2011 | 661 |
| 11 | Preventing and Managing Toxicities of High-Dose Methotrexate Hit paper breakdown → | 2016 | 659 |
| 12 | Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration Hit paper breakdown → | 2015 | 632 |
| 13 | Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update Hit paper breakdown → | 2011 | 628 |
| 14 | Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia Hit paper breakdown → | 1991 | 590 |
| 15 | Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus Hit paper breakdown → | 1999 | 570 |
| 16 | Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review Hit paper breakdown → | 2008 | 525 |
| 17 | NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia Hit paper breakdown → | 2010 | 522 |
| 18 | 2004 | 473 | |
| 19 | CREBBP mutations in relapsed acute lymphoblastic leukaemia Hit paper breakdown → | 2011 | 469 |
| 20 | 2010 | 426 |
About Ching‐Hon Pui
Ching‐Hon Pui is a scholar working on Public Health, Environmental and Occupational Health, Hematology, Pediatrics, Perinatology and Child Health, Oncology and Molecular Biology, having authored 656 papers that have together received 51.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (392 papers), Childhood Cancer Survivors' Quality of Life (180 papers), Acute Myeloid Leukemia Research (160 papers), Chronic Myeloid Leukemia Treatments (56 papers), Hematopoietic Stem Cell Transplantation (34 papers), Neuroblastoma Research and Treatments (28 papers), Neutropenia and Cancer Infections (26 papers) and Chronic Lymphocytic Leukemia Research (26 papers). The work is most often cited by research in Hematology (16.6k citations), Public Health, Environmental and Occupational Health (26.1k citations), Pediatrics, Perinatology and Child Health (13.8k citations), Genetics (4.5k citations) and Oncology (7.7k citations). Ching‐Hon Pui has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include William E. Evans, Mary V. Relling, James R. Downing, Raul C. Ribeiro, Scott C. Howard, Dario Campana, Jeffrey E. Rubnitz, John T. Sandlund, Susana C. Raimondi and Gaston K. Rivera. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Pediatric Blood & Cancer and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.